HomeCompareCHN vs ABBV

CHN vs ABBV: Dividend Comparison 2026

CHN yields 0.82% · ABBV yields 3.67%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ABBV wins by $20.1K in total portfolio value
10 years
CHN
CHN
● Live price
0.82%
Share price
$18.19
Annual div
$0.15
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.8K
Annual income
$0.08
Full CHN calculator →
ABBV
AbbVie Inc.
● Live price
3.67%
Share price
$168.90
Annual div
$6.20
5Y div CAGR
8.9%
Payout ratio
58%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.9K
Annual income
$1,154.43
Full ABBV calculator →

Portfolio growth — CHN vs ABBV

📍 ABBV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCHNABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CHN + ABBV cover 4 of 12 monthsgood coverage

Jan
ABBV
Feb
Mar
Apr
ABBV
May
Jun
Jul
ABBV
Aug
Sep
Oct
ABBV
Nov
Dec
CHN pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CHN
Annual income on $10K today (after 15% tax)
$69.95/yr
After 10yr DRIP, annual income (after tax)
$0.07/yr
ABBV
Annual income on $10K today (after 15% tax)
$312.02/yr
After 10yr DRIP, annual income (after tax)
$981.27/yr
At 15% tax rate, ABBV beats the other by $981.20/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CHN + ABBV for your $10,000?

CHN: 50%ABBV: 50%
100% ABBV50/50100% CHN
Portfolio after 10yr
$29.9K
Annual income
$577.26/yr
Blended yield
1.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

CHN
No analyst data
Altman Z
133.2
Piotroski
5/9
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+51.7% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CHN buys
0
ABBV buys
0
No recent congressional trades found for CHN or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCHNABBV
Forward yield0.82%3.67%
Annual dividend / share$0.15$6.20
Payout ratio50%58%
1-year div growth0%4.7%
5-year div CAGR-50%8.9%
Portfolio after 10y$19.8K$39.9K
Annual income after 10y$0.08$1,154.43
Total dividends collected$82.00$7.2K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CHN vs ABBV ($10,000, DRIP)

YearCHN PortfolioCHN Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$10,741$41.15$11,520$399.75$779.00ABBV
2$11,514$20.65$13,261$450.98$1.7KABBV
3$12,330$10.35$15,255$508.41$2.9KABBV
4$13,198$5.18$17,536$572.74$4.3KABBV
5$14,125$2.59$20,145$644.78$6.0KABBV
6$15,115$1.30$23,126$725.38$8.0KABBV
7$16,173$0.65$26,532$815.52$10.4KABBV
8$17,306$0.32$30,420$916.26$13.1KABBV
9$18,517$0.16$34,855$1,028.80$16.3KABBV
10$19,814$0.08$39,914$1,154.43$20.1KABBV

CHN vs ABBV: Complete Analysis 2026

CHNStock

The China Fund, Inc. is a closed ended equity mutual fund launched and managed by Allianz Global Investors U.S. LLC. It invests in the public equity markets of China that includes the People's Republic of China, Hong Kong, and Taiwan. The fund invests in stocks of companies operating across diversified sectors. It employs a combination of fundamental analysis with bottom-up approach and quantitative analysis to create its portfolio. The fund seeks to benchmarks the performance of its portfolio against the MSCI Golden Dragon Index. The China Fund, Inc. was formed on April 28, 1992 and is domiciled in the United States.

Full CHN Calculator →

ABBVHealthcare

AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.

Full ABBV Calculator →
📬

Get this CHN vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CHN vs SCHDCHN vs JEPICHN vs OCHN vs KOCHN vs MAINCHN vs JNJCHN vs MRKCHN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.